Mairs RJ - Search Results

1

Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy.

Rae C, Haberkorn U, Babich JW, Mairs RJ. Rae C, et al. Among authors: mairs rj. Radiat Res. 2015 Nov;184(5):482-93. doi: 10.1667/RR14173.1. Epub 2015 Oct 20. Radiat Res. 2015. PMID: 26484401

2

Gamma irradiation and targeted radionuclides enhance the expression of the noradrenaline transporter transgene controlled by the radio-inducible p21(WAF1/CIP1) promoter.

McCluskey AG, Mairs RJ, Sorensen A, Robson T, McCarthy HO, Pimlott SL, Babich JW, Champion S, Boyd M. McCluskey AG, et al. Among authors: mairs rj. Radiat Res. 2013 Mar;179(3):282-92. doi: 10.1667/RR3030.1. Epub 2013 Jan 21. Radiat Res. 2013. PMID: 23336184

3

The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells.

Rae C, Tesson M, Babich JW, Boyd M, Sorensen A, Mairs RJ. Rae C, et al. Among authors: mairs rj. J Nucl Med. 2013 Jun;54(6):953-60. doi: 10.2967/jnumed.112.113324. Epub 2013 Apr 24. J Nucl Med. 2013. PMID: 23616582 Free article.

4

Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs.

Tesson M, Rae C, Nixon C, Babich JW, Mairs RJ. Tesson M, et al. Among authors: mairs rj. J Pharm Pharmacol. 2016 Jul;68(7):912-21. doi: 10.1111/jphp.12558. Epub 2016 May 3. J Pharm Pharmacol. 2016. PMID: 27139157 Free PMC article.

5

Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells.

Rae C, Mairs RJ. Rae C, et al. Among authors: mairs rj. Int J Radiat Biol. 2017 Feb;93(2):194-203. doi: 10.1080/09553002.2017.1231946. Epub 2016 Oct 3. Int J Radiat Biol. 2017. PMID: 27600766 Free article.

6

Differential in radiosensitizing potency of enantiomers of the fatty acid synthase inhibitor C75.

Rae C, Babich JW, Mairs RJ. Rae C, et al. Among authors: mairs rj. Chirality. 2017 Jan;29(1):10-13. doi: 10.1002/chir.22668. Epub 2016 Nov 30. Chirality. 2017. PMID: 27901292 Free PMC article.

7

AMPK activation by AICAR sensitizes prostate cancer cells to radiotherapy.

Rae C, Mairs RJ. Rae C, et al. Among authors: mairs rj. Oncotarget. 2019 Jan 22;10(7):749-759. doi: 10.18632/oncotarget.26598. eCollection 2019 Jan 22. Oncotarget. 2019. PMID: 30774777 Free PMC article.

8

Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter.

McCluskey AG, Mairs RJ, Tesson M, Pimlott SL, Babich JW, Gaze MN, Champion S, Boyd M. McCluskey AG, et al. Among authors: mairs rj. J Nucl Med. 2012 Jul;53(7):1146-54. doi: 10.2967/jnumed.111.095943. Epub 2012 Jun 11. J Nucl Med. 2012. PMID: 22689924 Free article.

9

Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen species.

Rae C, Tesson M, Babich JW, Boyd M, Mairs RJ. Rae C, et al. Among authors: mairs rj. EJNMMI Res. 2013 Nov 13;3(1):73. doi: 10.1186/2191-219X-3-73. EJNMMI Res. 2013. PMID: 24219987 Free PMC article.

10

An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.

Nile DL, Rae C, Hyndman IJ, Gaze MN, Mairs RJ. Nile DL, et al. Among authors: mairs rj. BMC Cancer. 2016 Aug 11;16:621. doi: 10.1186/s12885-016-2656-8. BMC Cancer. 2016. PMID: 27515310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters